Back

Met-HeFT meta-analysis: Metformin in heart failure and ischemic heart disease: a systematic review and meta-analyses

30 August 2026 (08:53 - 09:01)
Organised by: Logo
Congress Presentation Part of: HOT LINE 6 Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Anders Hostrup Larsen

Goedstrup Hospital, Herning (Denmark)

14 More presentations in this session

Presentation thumbnail
H-HeFT: Hydralazin-Isosorbide Dinitrate in HFrEF
Professor L. Kober (Copenhagen, DK)
Presentation thumbnail
H-ISDN Meta-Analysis: Hydralazine-Isosorbide Dinitrate in HFrEF
Doctor J. Butt (Copenhagen, DK)
Presentation thumbnail
Discussant review - H-HeFT, H-ISDN Meta-Analysis
Professor J. McMurray (Glasgow, GB)
Presentation thumbnail
Panel discussion - H-HeFT, H-ISDN Meta-Analysis
Presentation thumbnail
Met-HeFT: Metformin and chronic heart failure
Professor H. Wiggers (Aarhus, DK)

Access the full session

Session thumbnail
HOT LINE 6

The Event

Event poster

ESC Congress 2026

30 August 2026 08:53 CET
You may be interested in
thumbnail
Congress Presentation
Metformin treatment in hyperglycemic patients with Ischemia and no obstructive coronary artery
17 May 2025
thumbnail
Congress Session
Clinical trials updates in medical therapy
19 May 2025
thumbnail
Congress Presentation
Metformin reduces the risk of hospitalization for heart failure in type 2 diabetes patients: a retrospective cohort analysis
3 September 2019
thumbnail
Congress Presentation
Effects of SGLT2 inhibitors on heart failure symptoms, quality of life and exercise capacity in patients with heart failure and preserved ejection fraction: A meta-analysis
1 December 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources